search
Back to results

Quick Large Balloon Dilatation for Removal of Large Bile Duct Stones (SHODBADI) (SHODBADI)

Primary Purpose

Pancreatitis, Acute, Bleeding, Cholangitis

Status
Recruiting
Phase
Not Applicable
Locations
Finland
Study Type
Interventional
Intervention
endoscopic short duration papillary large balloon dilation
Sponsored by
Helsinki University Central Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Pancreatitis, Acute

Eligibility Criteria

18 Years - 95 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Age >18 years
  • Common bile duct stone >10mm diameter

Exclusion Criteria:

  • Altered anatomy after surgery (B II, Roux-en-Y reconstruction)
  • Common bile duct cysts
  • Acute pancreatitis
  • Distal common bile duct stricture or tumor
  • Coagulation disorders
  • Ongoing coagulation medication
  • Pregnancy
  • Inability to give an informed consent

Sites / Locations

  • Helsinki University HospitalRecruiting
  • Turku University HospitalRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Active Comparator

Active Comparator

Active Comparator

Arm Label

short sphincterotomy +Short duration papillary large balloon dilation

full sphincterotomy + short duration papillary balloon dilation

previous sphincterotomy + short duration papillary balloon dilation

Arm Description

Patients with short sphincterotomy

Patients with full lenght sphincterotomy

Patients with previous sphincterotomy

Outcomes

Primary Outcome Measures

Rate of bleeding
need for additional intervention or need for blood transfusion and hemoglobin drop more than 2 gm/dL
Rate of pancreatitis
Plasma amylase rises >3 times the upper limit and newly developed stomach ace more than 24h
Rate of cholangitis
Fever >38

Secondary Outcome Measures

Full Information

First Posted
September 20, 2021
Last Updated
February 28, 2023
Sponsor
Helsinki University Central Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT05061680
Brief Title
Quick Large Balloon Dilatation for Removal of Large Bile Duct Stones (SHODBADI)
Acronym
SHODBADI
Official Title
Endoscopic Papillary Short Duration Large Balloon Dilatation for Removal of Large Bile Duct Stones: a Prospective Multicenter Study of Short and Long-term Adverse Events
Study Type
Interventional

2. Study Status

Record Verification Date
February 2023
Overall Recruitment Status
Recruiting
Study Start Date
April 5, 2021 (Actual)
Primary Completion Date
December 31, 2025 (Anticipated)
Study Completion Date
December 31, 2026 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Helsinki University Central Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
Yes
Data Monitoring Committee
No

5. Study Description

Brief Summary
ESGE guidelines suggests 30-60 seconds endoscopic large balloon papillary dilation from the disappearance of the waist of the papilla. The investigators have good results in stone removal with much quicker dilatations when the cholangiogram is followed and the dilation is finished as soon as the disappearance of the waist of the papilla is seen. This Scandinavian multicenter prospective study is especially interested in stone clearance rate and short and long-term adverse events such as pancreatitis, cholangitis, bleeding, perforations, residual biliary stones, and newly developing biliary stones.
Detailed Description
This study is planned as a multicenter Scandinavian prospective study including all the patients >18 years with >10mm diameter common bile duct stones visible in cholangiogram. Before ERCP all patient will be informed about this trial, and if they agree to participate this study, they need to give a written informed consent. The endoscopists will decide whether the first step will be large EST and stone extraction or small EST and dilatation. If simple EST does not success, the dilatation will remain as a rescue method. The diameter of dilatation balloon cannot exceed the diameter of common bile duct above the papilla. Cholangiogram is followed when papilla is dilated and the dilatation will be ended when the waist of the papilla disappears. The duration of the dilatation measured, but it does not define the ending of dilatation. All adverse events will be recorded one month and a year after the procedure. Classification of the patients: EST and stone extraction EPLBD when EST and stone extraction did not succeed Short EST and EPLBD The investigators will collect the information of adverse events such as bleeding, pancreatitis, cholangitis with patient questionnaire as well as from the patient records one month and a year after the procedure

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pancreatitis, Acute, Bleeding, Cholangitis

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
600 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
short sphincterotomy +Short duration papillary large balloon dilation
Arm Type
Active Comparator
Arm Description
Patients with short sphincterotomy
Arm Title
full sphincterotomy + short duration papillary balloon dilation
Arm Type
Active Comparator
Arm Description
Patients with full lenght sphincterotomy
Arm Title
previous sphincterotomy + short duration papillary balloon dilation
Arm Type
Active Comparator
Arm Description
Patients with previous sphincterotomy
Intervention Type
Device
Intervention Name(s)
endoscopic short duration papillary large balloon dilation
Intervention Description
During the large balloon papillary dilation investigators follow the cholangiogram and stop the dilatation as soon as the disappearance of the waist of the papilla is noticed.
Primary Outcome Measure Information:
Title
Rate of bleeding
Description
need for additional intervention or need for blood transfusion and hemoglobin drop more than 2 gm/dL
Time Frame
30 days
Title
Rate of pancreatitis
Description
Plasma amylase rises >3 times the upper limit and newly developed stomach ace more than 24h
Time Frame
30 days
Title
Rate of cholangitis
Description
Fever >38
Time Frame
30 days

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
95 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age >18 years Common bile duct stone >10mm diameter Exclusion Criteria: Altered anatomy after surgery (B II, Roux-en-Y reconstruction) Common bile duct cysts Acute pancreatitis Distal common bile duct stricture or tumor Coagulation disorders Ongoing coagulation medication Pregnancy Inability to give an informed consent
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Mia Rainio, MD, PhD
Phone
+358505833060
Email
mia.rainio@hus.fi
First Name & Middle Initial & Last Name or Official Title & Degree
Leena Kylänpää, MD, PhD
Phone
+35894711
Email
leena.kylanpaa@hus.fi
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Mia Rainio, Md, PhD
Organizational Affiliation
Helsinki University Central Hospital
Official's Role
Study Director
Facility Information:
Facility Name
Helsinki University Hospital
City
Helsinki
Country
Finland
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Mia Rainio, MD, PhD
Phone
+358505833060
Email
mia.rainio@hus.fi
First Name & Middle Initial & Last Name & Degree
Leena Kylänpää, Md PhD
Phone
+35894711
Email
leena.kylanpaa@hus.fi
Facility Name
Turku University Hospital
City
Turku
Country
Finland
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Juha Grönroos, Professor
Phone
+358 2 3130000
Email
juha.gronroos@tyks.fi

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Quick Large Balloon Dilatation for Removal of Large Bile Duct Stones (SHODBADI)

We'll reach out to this number within 24 hrs